PSA can degrade IGFBP3 and then decrease its binding with IGF-I to release more active IGF-I, thus potentiating IGF-I-induced OB proliferation and activation and PCa osteoblastic bone metastasis (44). The gene discussed is IGF1; the disease is posterior cortical atrophy.